CKD Venture Capital Corporation
24
3M
21
0.89
3
0.12
1
- Areas of investment
Summary
In 1997 was created CKD Venture Capital Corporation, which is appeared as VC. The main office of represented VC is situated in the Seoul. The fund was located in Asia if to be more exact in South Korea.
Among the various public portfolio startups of the fund, we may underline Urbanbase. For fund there is a match between the country of its foundation and the country of its the most frequent investments - South Korea. Among the most popular fund investment industries, there are Geospatial, Artificial Intelligence. Besides, a startup needs to be aged 2-3 years to get the investment from the fund.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the CKD Venture Capital Corporation, startups are often financed by SparkLabs Global Ventures, SparkLabs Accelerator, Small and Medium Business Administration. The meaningful sponsors for the fund in investment in the same round are Shinhan Financial Group, SL Investment, Magellan Technology Investment.
The top activity for fund was in 2017. The fund is constantly included in less than 2 investment rounds annually. The common things for fund are deals in the range of 1 - 5 millions dollars.
Investments analytics
Analytics
- Total investments
- 24
- Lead investments
- 3
- Exits
- 1
- Rounds per year
- 0.89
- Follow on index
- 0.12
- Investments by industry
- Information Technology (7)
- Health Care (5)
- Medical (3)
- Biotechnology (3)
- Software (2) Show 45 more
- Investments by region
-
- South Korea (24)
- Peak activity year
- 2022
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 4
- Avg. valuation at time of investment
- 4M
- Group Appearance index
- 0.88
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Cenyx Biotech | 12 Aug 2019 | Health Diagnostics, Therapeutics, Nanotechnology | Seed | 3M | Seoul, Seoul-t'ukpyolsi, South Korea |
| ROBOS | 13 Feb 2024 | Robotics, Industrial Automation | Early Stage Venture | 6M | Taegu-jikhalsi, Daegu, South Korea |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.